JAY R GOLDSTEIN
Accountancy in Newton, MA

2009017, Jul 9, 2009

Jan 7, 2009

12/349671

Jay Goldstein - Newton MA, US

LioLabs LLC - Newton MA

A61K 31/7048, A61K 31/65, A61K 31/43, A61K 31/397, A61K 31/545, A61K 31/70, A61K 31/56, A61P 17/00

514 29, 514154, 514192, 51421015, 514200, 514 25, 514171

Methods for treating perioral dermatitis are described herein. The method includes administering topically a composition containing an effective amount of a systemic or topical antibiotic and a corticosteroid. The concentration of the antibiotic is from about 0.01% to about 5% by weight of the composition and the concentration of the corticosteroid is from about 0.01% to about 5% by weight of the composition. The composition can contain one or more pharmaceutically acceptable excipients and/or carriers. The compositions can be formulated as a lotion, cream, gel, ointment, paste, powder, solution, suspension, spray, foam, or patch.

4981145, Jan 1, 1991

Oct 24, 1989

7/426115

Jay A. Goldstein - Newton MA

A61B 500

128760

A sampling device and method for collection of sebum secreted by a person for determination of the person's skin oil characteristics includes a sampling element having a backing member of liquid impervious material. An absorbent material is disposed upon the backing member for absorbing sebum secreted by a person's skin, the absorbent material defining an absorption surface. A device is provided for disposing the absorption surface in contact with a region of the person's skin during the predetermined sampling period. The element is sealed within a liquid impervious pouch formed at least in part of the backing member during transport of the collected sebum to a site for measurement. A method for collection of sebum for selection of facial cosmetics of complementary formula is also described, including the step of providing a line of facial cosmetics formulated with oil and the like present at stepped levels preselected to complement a range of sebum production.

2008031, Dec 25, 2008

Jun 25, 2007

11/768053

Jay A. Goldstein - Newton MA, US
Bernard Grubstein - Wayland MA, US
Michael Rothman - Newton MA, US
Patrea L. Pabst - Dewey Rose GA, US

LioLabs LLC - Newton MA

A61K 33/24, A61K 33/08, A61K 33/30, A61L 15/18, A61K 33/12

424447, 424617, 424642, 424683, 424689

Compositions for the treatment of wounds and/or scars are described herein. The compositions contain between 1 and up to 30% by weight, more preferably between 1 and 20%, most preferably between about 5 and 10% by weight particles, such as titanium dioxide or a similar material in a pharmaceutically acceptable base or carrier, such as petrolatum. The compositions are less greasy than petrolatum alone, and thus are more aesthetically pleasing. The compositions exhibit occlusive properties comparable to petrolatum. The compositions are absorbed into the skin, unlike petrolatum, and exhibit significant wound healing characteristics not observed with petrolatum alone. In one embodiment, the pharmaceutically acceptable base is petrolatum and the particles are titanium dioxide. The compositions can be used to treat complex, hard to heal wounds, such as diabetic ulcers; pressure sores, such as bed sores; lacerations; bite wounds; burns; penetrating wounds; surgical wounds, etc. The composition can also be used to promote normal healing of scar tissue. The compositions can also be used for the topical delivery of one or more active agent. The compositions can be used to reduce fine lines and wrinkles, and to rehydrate skin or to treat dry skin.

2012016, Jun 28, 2012

Jan 13, 2012

13/349929

Jay A. Goldstein - Newton MA, US
Michael Rothman - Newton MA, US

A61K 31/56, A61P 29/00, A61P 31/10, A61K 31/58, A61K 31/573

514171

A topical composition and the method using the composition, which contains an antifungal agent and a low potency anti-inflammatory steroid which is safe and effective such as desonide or its derivative. The low potency steroid agent does not cause side effects such as skin atrophy, striae and hypopigmentation. The composition can be formulated in a dosage form such as a cream, ointment, gel, lotion, foam, powder, aerosol, spray, shampoo, or liquid solution. The composition can be used to treat a fungal disease such as tinea pedis, tinea capitis, tinea corporis, tinea versicolor, tinea cruris, and candidiasis as well as intertriginous dermatitis complicated by candidiasis.

8232304, Jul 31, 2012

Oct 23, 2003

10/691928

Jay A. Goldstein - Newton MA, US
Michael Rothman - Newton MA, US

G & R Pharmaceuticals, LLC - Newton MA

A61K 31/415, A61K 31/58, A61K 31/56, A61K 9/06, A61K 9/08, A61K 9/12, A61K 9/14

514396, 514171, 514174, 514179, 514182, 514772, 424489, 424 701

A topical composition and the method using the composition, which contains an antifungal agent and a low potency anti-inflammatory steroid which is safe and effective such as desonide or its derivative. The low potency steroid agent does not cause side effects such as skin atrophy, striae and hypopigmentation. In a representative example, the low potency anti-inflammatory steroid has the following structure:.